OHC Cancer Specialist Closes the Palliative Care Knowledge Gap

Prasad R. Kudalkar, MD, Medical Oncologist and Hematologist with OHC

A recent study conducted by researchers at the University of Oklahoma Health Sciences Center revealed that nearly 90% of American adults have inadequate knowledge of palliative care. Why is there a tremendous knowledge gap about a healthcare service... Read More

27-Year Breast Cancer Survivor and OHC Patient Discovers Her Strength

OHC, Specialists in the Treatment of Adult Cancers and Blood Disorders

Like 90% of women who receive a normal mammogram result each year, Cheryl Wilde breathed a huge sigh of relief when she was told her results were clear. Yet, although she received what she thought was excellent news that day in 1994, her breast... Read More

Next-Generation Sequencing: A Valuable Tool in Creating a Personalized Treatment Plan for Cancer Patients

OHC, Specialists in the Treatment of Adult Cancers and Blood Disorders

The 2017 FDA approval of Keytruda for patients whose cancers have specific genetic features was the first time the agency approved a cancer treatment based on a common biomarker rather than the location in the body where the tumor began to grow.... Read More

Attentive and Expedient Care of OHC Cancer Specialists Has a Lasting Impression on an Ovarian Cancer Survivor

OHC, Specialists in the Treatment of Adult Cancers and Blood Disorders

Ovarian cancer awareness remains on the forefront of the minds of OHC’s cancer specialists. Ovarian cancer is most often diagnosed in its late stages as its presenting symptoms are typically subtle and sometimes mistaken for more common conditions.... Read More

OHC Clinical Trial Impacts FDA Approval of Promising Therapy for Aggressive Breast Cancer

OHC, Specialists in the Treatment of Adult Cancers and Blood Disorders

With an enduring interest in offering hope to patients with aggressive cancers, OHC participated in a clinical trial that recently resulted in the FDA approval of a new breast cancer treatment. To help develop new treatment options for... Read More

OHC Ovarian Cancer Survivor: Your Attitude Impacts Your Healing

OHC, Specialists in the Treatment of Adult Cancers and Blood Disorders

Imagine going to the doctor with some abdominal pain. You’re not expecting the worst. Appendicitis and a hernia are ruled out and a blood test and chest X-ray are ordered. Upon receiving additional test results, your doctor immediately admits you... Read More

OHC's Research Influences the FDA Approval of Another Cancer Therapy

OHC, Specialists in the Treatment of Adult Cancers and Blood Disorders

In its relentless pursuit of the newest and most innovative cancer treatments, OHC has recently played a role in three new FDA approved therapies. On August 10, the FDA approved Lenvima (lenvatnib) plus Keytruda (pembrolizumab) for adults with... Read More

Last week, Cancer Family Care (CFC) hosted its 19th annual Joslin Haggart Yeiser Unsung Hero Awards to honor patients, caregivers, and oncology professionals who quietly change the lives of those living with cancer. The event recognized 2020 heroes... Read More

OHC Cancer Survivor on a Mission to Bring TLC to Chemotherapy Patients

OHC, Specialists in the Treatment of Adult Cancers and Blood Disorders

Karen Herzog, an ovarian cancer survivor, knows all too well what it’s like to cope with cancer during treatment. She was a patient of OHC’s Cynthia C. Chua, MD, and Sarah Wilson, MSN, APRN. It wasn’t long after she completed her chemotherapy... Read More

OHC Continues to Bolster Efforts of FDA Approvals

OHC, Specialists in the Treatment of Adult Cancers and Blood Disorders

OHC is part of the nation’s largest research network specializing in oncology clinical trials, US Oncology Research, which has played a role in more than 100 FDA approved cancer therapies. OHC’s pioneers in research continue to lead in cancer... Read More